Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1

Neeltje van Doremalen, Trenton Bushmaker, Dylan H. Morris, Myndi G. Holbrook, Amandine Gamble, Brandi N. Williamson, Azaibi Tamin, Jennifer L. Harcourt, Natalie J. Thornburg, Susan I. Gerber, James O. Lloyd-Smith, Emmie de Wit, Vincent J. Munster
doi: https://doi.org/10.1101/2020.03.09.20033217
Neeltje van Doremalen
1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Trenton Bushmaker
1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dylan H. Morris
2Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Myndi G. Holbrook
1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amandine Gamble
3Department of Ecology and Evolutionary Biology, University of California, Los Angeles, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brandi N. Williamson
1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Azaibi Tamin
4Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer L. Harcourt
4Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie J. Thornburg
4Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan I. Gerber
4Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James O. Lloyd-Smith
3Department of Ecology and Evolutionary Biology, University of California, Los Angeles, Los Angeles, CA, USA
5Fogarty International Center, National Institutes of Health, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emmie de Wit
1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent J. Munster
1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vincent.munster@nih.gov
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

To the Editor

A novel human coronavirus, now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, referred to as HCoV-19 here) that emerged in Wuhan, China in late 2019 is now causing a pandemic1. Here, we analyze the aerosol and surface stability of HCoV-19 and compare it with SARS-CoV-1, the most closely related human coronavirus.2 We evaluated the stability of HCoV-19 and SARS-CoV-1 in aerosols and on different surfaces and estimated their decay rates using a Bayesian regression model (see Supplementary Appendix). All experimental measurements are reported as mean across 3 replicates.

HCoV-19 remained viable in aerosols throughout the duration of our experiment (3 hours) with a reduction in infectious titer from 103.5 to 102.7 TCID50/L, similar to the reduction observed for SARS-CoV-1, from 104.3 to 103.5 TCID50/mL (Figure 1A). HCoV-19 was most stable on plastic and stainless steel and viable virus could be detected up to 72 hours post application (Figure 1A), though the virus titer was greatly reduced (plastic from 103.7 to 100.6 TCID50/mL after 72 hours, stainless steel from 103.7 to 100.6 TCID50/mL after 48 hours). SARS-CoV-1 had similar stability kinetics (polypropylene from 103.4 to 100.7 TCID50/mL after 72 hours, stainless steel from 103.6 to 100.6 TCID50/mL after 48 hours). No viable virus could be measured after 4 hours on copper for HCoV-19 and 8 hours for SARS-CoV-1, or after 24 hours on cardboard for HCoV-19 and 8 hours for SARS-CoV-1 (Figure 1A).

Figure 1.
  • Download figure
  • Open in new tab
Figure 1.

Viability of SARS-CoV-1 and HCoV-19 in aerosols and on different surfaces. A) SARS-CoV and HCoV-19 were aerosolized in a rotating drum maintained at 21-23°C and 65% RH over three hours. Viable virus titer is shown in TCID50/L air. For surfaces, viruses were applied on copper, cardboard, steel and plastic maintained at 21-23°C and 40% RH over seven days. Viable virus titer is shown in TCID50/mL collection medium. All samples were quantified by end-point titration on Vero E6 cells. Plots show the mean and standard error across three replicates. B) Regression plots showing predicted decay of virus titer over time; titer plotted on a logarithmic scale. Points show measured titers and are slightly jittered along the time axis to avoid overplotting. Lines are random draws from the joint posterior distribution of the exponential decay rate (negative of the slope) and intercept (initial virus titer), thus visualizing the range of possible decay patterns for each experimental condition. 150 lines per panel: 50 lines from each plotted replicate. C) Violin plots showing posterior distribution for half-life of viable virus based on the estimated exponential decay rates of virus titer. Dot shows the posterior median estimate and black line shows a 95% credible interval. Experimental conditions are ordered by posterior median half-life for HCoV-19. Dotted line shows Limit of Detection (LOD), 3.33 × 100.5 TCID50/L air for aerosols, 100.5 TCID50/mL media for plastic, steel and cardboard and 101.5 TCID50/mL media for copper.

Both viruses exhibited exponential decay in virus titer across all experimental conditions, as indicated by linear decrease in the log10TCID50/mL over time (Figure 1B). HCoV-19 and SARS-CoV-1 exhibited similar half-lives in aerosols, with median estimates around 1.1-1.2 hours, and 95% credible intervals of [0.64, 2.64] hours for HCoV-19 and [0.78, 2.43] hours for SARS-CoV-1 (Figure 1C, Table S1). Half-lives on copper were also similar between the two viruses. On cardboard, HCoV-19 showed a considerably longer half-life than SARS-CoV-1. Both viruses showed longest viability on stainless steel and plastic: the median half-life estimate for HCoV-19 was roughly 5.6 hours on steel and 6.8 hours on plastic (Figure 1C, Table S1). Estimated differences in half-life between the two viruses were small except for on cardboard (Figure 1C, Table S1). Individual replicate data were noticeably noisier for cardboard than other surfaces (Figures S1–S5), so we advise caution in interpreting this result.

Our findings show that the stability of HCoV-19 and SARS-CoV-1 under the experimental circumstances tested is similar. This indicates that differences in the epidemiology of these viruses likely arise from other factors, including high viral loads in the upper respiratory tract and the potential for individuals infected with HCoV-19 to shed and transmit the virus while asymptomatic3,4. Our results indicate that aerosol and fomite transmission of HCoV-19 are plausible, as the virus can remain viable and infectious in aerosols for multiple hours and on surfaces up to days. This echoes the experience with SARS-CoV-1, where these modes of transmission were associated with nosocomial spread and superspreading events5, and provides guidance for pandemic mitigation measures.

Data Availability

data is available upon request

References

  1. 1.↵
    Coronavirus disease (COVID-2019) situation reports. 2020. (Accessed 26th of February 2020, at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/.)
  2. 2.↵
    Wu A, Peng Y, Huang B, et al. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host Microbe 2020.
  3. 3.↵
    Bai Y, Yao L, Wei T, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 2020.
  4. 4.↵
    Zou L, Ruan F, Huang M, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med 2020.
  5. 5.↵
    Chen YC, Huang LM, Chan CC, et al. SARS in hospital emergency room. Emerg Infect Dis 2004;10:782–8.
    OpenUrlCrossRefPubMedWeb of Science
Back to top
PreviousNext
Posted March 13, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1
Neeltje van Doremalen, Trenton Bushmaker, Dylan H. Morris, Myndi G. Holbrook, Amandine Gamble, Brandi N. Williamson, Azaibi Tamin, Jennifer L. Harcourt, Natalie J. Thornburg, Susan I. Gerber, James O. Lloyd-Smith, Emmie de Wit, Vincent J. Munster
medRxiv 2020.03.09.20033217; doi: https://doi.org/10.1101/2020.03.09.20033217
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1
Neeltje van Doremalen, Trenton Bushmaker, Dylan H. Morris, Myndi G. Holbrook, Amandine Gamble, Brandi N. Williamson, Azaibi Tamin, Jennifer L. Harcourt, Natalie J. Thornburg, Susan I. Gerber, James O. Lloyd-Smith, Emmie de Wit, Vincent J. Munster
medRxiv 2020.03.09.20033217; doi: https://doi.org/10.1101/2020.03.09.20033217

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (140)
  • Cardiovascular Medicine (1950)
  • Dentistry and Oral Medicine (253)
  • Dermatology (185)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (702)
  • Epidemiology (11117)
  • Forensic Medicine (8)
  • Gastroenterology (628)
  • Genetic and Genomic Medicine (3190)
  • Geriatric Medicine (309)
  • Health Economics (563)
  • Health Informatics (2046)
  • Health Policy (864)
  • Health Systems and Quality Improvement (785)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12736)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (318)
  • Medical Ethics (92)
  • Nephrology (336)
  • Neurology (2997)
  • Nursing (165)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1560)
  • Ophthalmology (478)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (382)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2794)
  • Public and Global Health (5607)
  • Radiology and Imaging (1099)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (763)
  • Rheumatology (340)
  • Sexual and Reproductive Health (313)
  • Sports Medicine (289)
  • Surgery (347)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)